🇺🇸 FDA
Patent

US 11001564

Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same

granted A61PA61P31/20

Quick answer

US patent 11001564 (Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same) held by ARBUTUS BIOPHARMA CORPORATION expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARBUTUS BIOPHARMA CORPORATION
Grant date
Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P31/20